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Abstract
For more than 3500 years, urinary catheters have been used to drain the bladder when it fails to
empty. For people with impaired bladder function and for whom the method is feasible, clean
intermittent self-catheterization is the optimal procedure. For those who require an indwelling
catheter, whether short- or long-term, the self-retaining Foley catheter is invariably used, as it
has been since its introduction nearly 80 years ago, despite the fact that this catheter can cause
bacterial colonization, recurrent and chronic infections, bladder stones and septicaemia,
damage to the kidneys, the bladder and the urethra, and contribute to the development of
antibiotic resistance. In terms of medical, social and economic resources, the burden of urinary
retention and incontinence, aggravated by the use of the Foley catheter, is huge. In the UK, the
harm resulting from the use of the Foley catheter costs the National Health Service between
£1.0–2.5 billion and accounts for 2100 deaths per year. Therefore, there is an urgent need for
the development of an alternative indwelling catheter system. The research agenda is for the
new catheter to be easy and safe to insert, either urethrally or suprapubically, to be retained
reliably in the bladder and to be withdrawn easily and safely when necessary, to mimic natural
physiology by filling at low pressure and emptying completely without damage to the bladder,
and to have control mechanisms appropriate for all users.
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1. A brief history of the development of the urinary
catheter
The word catheter is derived from the ancient Greek
kathie´nai, which literally means ‘‘to thrust into’’ or ‘‘to
send down’’.
The main events in the chronology of the recorded
development of the urinary catheter are identified in
Table 1. Before the widespread introduction of the Foley
catheter [14] in the 1930s, catheterization was almost
exclusively for the treatment of urinary retention in the
male. The early catheters (some examples are shown in
Figure 1) were usually rigid and they were designed—to the
extent that they were designed at all—for intermittent
catheterization. Figure 2 shows what was involved, although
most sufferers presumably would have preferred a greater
degree of privacy. Urinary retention was—and is—rare in
women. Urinary incontinence was not a medical emergency:
it was left as a personal embarrassment for men and women
alike, who generally adopted their own idiosyncratic methods
of coping with the disability. The indwelling Foley catheter,
however, made both short- and long-term catheterization
feasible for both males and females and this opened up a new
era in the management of urinary retention and incontinence.
It also opened up a Pandora’s box of medical conditions and
adverse events.
2. Bladder function and catheterization
The urinary tract system (Figure 3) produces, stores and
excretes urine from the body. In the adult, under normal
conditions of hydration and temperature, the kidneys con-
tinuously filter the blood to produce 1ml of urine per
minute, equivalent to 1500ml per day. Urine from the
kidneys is transported via the ureters to the bladder. The
capacity of the bladder is variable: a healthy bladder can
normally hold 350–500ml. Three sets of muscles control the
flow of urine from the bladder via the urethra. The internal
sphincter is formed by the involuntary smooth muscle of the
bladder wall, located at the base of the bladder where it joins
 2015 The Author(s). Published by Taylor & Francis.
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the urethra. The external sphincter which surrounds the
proximal part of the urethra is formed by striated muscle and
is, thus, under voluntary control. Third, the pelvic floor
muscles act as a sling to support the bladder and urethra and
provide additional control. Urine flow is initiated by the
voluntary relaxation of the external sphincter muscle which,
by reflex action, triggers contraction of the bladder muscle
and opening of the internal sphincter.
In the normal urinary tract, the regular flushing of the
urethra as the bladder empties helps to impede the ascending
infection of the tract by the bacteria that normally colonize the
periurethral skin. Any bacteria that manage to migrate into the
bladder are also washed out during micturition. In addition,
the bladder is lined by urothelial cells coated with a
glycosaminoglycan mucin, which provides a surface resistant
to the adherence of bacteria. Bacterial adherence, when it
does occur, initiates invasion of the urothelium. This activates
microbial-sensing proteins in the superficial umbrella cells,
triggering the host defences with a cascade of cellular and
molecular effectors to eliminate the bacteria [18].
In people with impaired bladder function, whether reten-
tion or incontinence, a safe and reliable system is required
to collect and contain the urine, whether for short- or long-
term use.
In those males and females for whom the method is
feasible, clean intermittent self-catheterization is the optimal
procedure to manage urinary retention [19]. This mimics
normal bladder function, allowing the bladder to fill and
periodically to empty completely, thus minimizing the risk of
infection. Although some find the procedure uncomfortable
and distasteful, with practice clean intermittent self-catheter-
ization is usually quite easy to perform. Whilst observing a
Table 1. Some important events in the history of the development of the urinary catheter.
Date Devices and comments Reference
1500 BC Earliest record in an ancient Egyptian papyrus (the Ebers papyrus) of treatment of urinary retention by
means of transurethral bronze tubes, reeds, straws and curled-up palm leaves.
Hanafy et al. [1]
400 BC References in Hippocratic writings to the use of malleable lead tubes. Milne [2]
79 AD An S-shaped silver tube was found during the excavation of Pompei, evidently for the treatment of urinary
retention.
Nacey and Delahunt [3]
900s Malleable silver tube with numerous side holes which, according to Albucasis (Abu al-Qasim Khalaf ibn
al-Abbas Al-Zahrawi) (936–1013), apparently resulted in easier insertion.
Hanafy et al. [4]
1100s Chinese records of the treatment of urinary retention by transurethral insertion of hollow leaves of onion
(Allium fistulosum). These were often hard to pass and rigid wood or metal tubes were alternatively
used.
Herman [5], Hume [6]
1500s First record by Fabricius of Acquapendente (1537–1619) of indwelling wax-impregnated cloth catheter
moulded on silver sound, to reduce incidence of damage due to repeated catheterization.
Murphy [7]
1564 Ambroise Pare´ (1510–1590) devised a silver tube with a long gentle curve for easier insertion. Pare´ [8]
1600s Jan-Baptiste van Helmont (1578–1644) described a chamois skin catheter impregnated with white lead
and linseed oil, inserted over a whalebone stylet. Later, wound silver wire was used to prevent collapse,
with external grooves filled with wax, tallow or bound with fine gut. Putrefaction of the chamois skin
was a major problem.
Murphy [7]
1684 Cornelius van Solingen (1641–1687) devised a silver wire helical tube covered with parchment held in
place by silk thread and coated with wax.
Mattelaer and Billiet [9]
1700s Jean Louis Petit (1674–1750) devised a silver tube with double curve. This device was less satisfactory
than its immediate predecessors.
Petit [10]
1731 Jacques de Garengeot (1688–1759) devised a silver tube with pronounced curve and fine stylet with small
terminal rounded tip to occlude the lumen during insertion.
de Garengeot [11]
1750s Theden of Berlin and Bernard of Paris independently used a natural rubber gum coating of silk closely
wound over a brass sound, finished with varnish to overcome stickiness. However, the varnish soon
cracked, there was no method for reliable retention and they soon became blocked by encrustation.
Murphy [7], Thomas [12]
1752 Benjamin Franklin (1706–1790) devised a silver wire helical tube rubbed with tallow to fill the external
grooves, for use as a catheter by his brother John when suffering from urinary retention due to ‘‘the
stone’’. Later, Benjamin Franklin used it personally when suffering from the same condition.
Nacey and Delahunt [3]
1836 Louis Auguste Mercier (1811–1882) invented the coude´ (elbow) catheter Mattelaer and Billiet [9]
1841 Mercier developed the bi-coude´ (double elbow) catheter, with which insertion was much easier. Mattelaer and Billiet [9]
1850s Auguste Ne´talon (1807–1873) developed a vulcanized rubber (latex) catheter, including the solid-tip and
a single-eye. It was retained by adhesive tape or by a stitch (although neither method was satisfactory).
Mattelaer and Billiet [9]
1855 Jean Franc¸ois Reybard (1795–1863) invented a self-retaining catheter, consisting of a device with two
channels, one for draining the urine and the other to inflate a balloon close to the tip to retain the
catheter in the bladder
Reybard [13]
1929 Development of the ‘‘modern’’ balloon-based self-retaining catheter. In the device constructed by the C R
Bard Company to the design of Dr Frederic Foley, a rubber balloon was attached with fine silk and
waterproof cement close to the tip of a rubber catheter with a longitudinal groove which
accommodated a fine tube to inflate the balloon with water. Bard placed Foley’s device on the market
in 1933. Foley’s original application of his now-eponymous catheter was for post-prostatectomy
haemostasis, but its wider application in the management of urinary incontinence and retention soon
became commonplace, although the latex frequently caused urethritis and urethral strictures, and
encrustration and infection were almost inevitable with longer-term catheterization.
Foley [14]
1968 Introduction of catheters constructed from silicone elastomer, reducing the incidence of urethritis and the
rates of encrustration and infection.
Mangelson et al. [15]
2001 Introduction of chemical impregnation and ‘‘antimicrobial’’ coating, particularly silver, aimed at
inhibiting the formation of surface biofilms and encrustation. These can reduce the risk of catheter-
induced urinary tract infection, but only by 2–3 weeks.
Maki and Tambyah [16]
2 R. C. L. Feneley et al. J Med Eng Technol, Early Online: 1–12
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high standard of cleanliness, the patient inserts a flexible
catheter (typically a plastic tube, with drainage eyes adjacent
to its rounded closed tip) into the urethra until urine starts to
flow, drains the urine directly into a toilet bowl or into a
suitable container for later disposal and withdraws the
catheter when the flow ceases. The procedure needs to be
repeated six or seven times a day, depending on the volume of
residual urine. In the UK, catheters tend to be used only once,
but randomized controlled trials are being undertaken to
assess whether multiple uses of the same catheter might be
acceptable. In a study of 172 adults (68 male, 104 female),
seven were unable or unwilling to adopt the technique, but, for
the remainder, the mean infection rate was only one per 14
patient-months [20].
In patients for whom clean intermittent self-catheterization
is not possible, an indwelling catheter has to be used.
Depending on the clinical indication, the duration of
catheterization may be short- or long-term. A long-term
urinary catheter is defined as one that is in place for more than
30 days.
For male patients with urinary incontinence, one possibil-
ity for short- or long-term use is the external or condom
catheter. This consists of a sheath that fits snuggly over the
penis and which has a tube at its tip to transport urine to a
collection bag, which may be strapped to the leg and emptied
periodically. Although this is superficially an attractive
approach, it does have several significant disadvantages. Up
to 40% of condom catheter users develop urinary tract
infections [21], 15% suffer from inflammation, ulceration,
necrosis, gangrene or constriction of the skin of the penis [22]
and there is the ever-present risk of detachment of the condom
and urine leakage. Moreover, the nursing time required for
condom catheter care is considerable [23]. In summary, the
condom catheter is far from satisfactory in the management of
Figure 1. Tubular silver catheters devised by Ambroise Pare´
(1510–1590), with long gentle curves (they are known as coude´
catheters) to permit easier insertion [8].
Figure 2. Urinary catheterization in the middle ages [17].
Figure 3. The urinary tract.
DOI: 10.3109/03091902.2015.1085600 Urinary catheters 3
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male urinary incontinence; it does, however, have a useful
application in the non-invasive measurement of bladder
pressure [24].
The eponymous indwelling balloon-retained catheter
(Figure 4) now in worldwide use was conceived by the
American urologist Frederic Foley nearly 80 years ago to
provide continuous urinary drainage and to control bleeding
while haemostasis occurs, following transurethral prostatec-
tomy [14]. It soon became apparent, however, that the use of
the Foley catheter was a solution to the general problems of
urinary retention and incontinence. From the outset, buckets
or open flasks were used for urine collection: it was not until
the 1960s that a bag that could be strapped to the patient’s leg
was introduced as an hygienic and more aesthetically
acceptable alternative.
The design of the Foley catheter is simple. As shown in
Figure 4, the catheter typically has two channels, the drainage
channel for the passage of urine and the inflation channel, to
allow the balloon at the end of the catheter to be inflated with
sterile water from a syringe, to retain the catheter within the
bladder. The smooth rounded tip of the catheter extends
beyond the balloon and one or more eye-holes are cut in the
tube adjacent to the tip to allow urine to drain. Were it not for
its complications (discussed in Section 4), it would often be
desirable for a Foley catheter to be able to be in place for up
to 12 weeks before the possibility of mechanical failure of
the balloon would dictate its replacement.
The principal reasons for indwelling catheterization are as
follows:
(a) to permit urinary drainage in patients with neurological
conditions which cause bladder dysfunction;
(b) to manage urinary incontinence in patients lacking
cognitive function;
(c) to minimize skin breakdown and pressure ulcers in
paralysed, comatose or terminally ill patients;
(d) to irrigate the bladder;
(e) to administer chemotherapy;
(f) to aid in urological surgery or other surgery on contigu-
ous structures;
(g) to obtain accurate measurements of urinary output in
critically ill or post-operative patients;
(h) to empty the bladder during childbirth; and
(i) to undertake urodynamic studies (such as pressure
measurements).
Of these, (a), (b) and (c) are likely to be for long-term
catheterization.
Bladder drainage may be performed by passing a Foley
catheter through the natural urethral passage (termed trans-
urethral catheterization) or by creating an artificial track
between the lower abdominal wall and the bladder (supra-
pubic catheterization), as shown in Figure 5. Transurethral
catheterization is the simpler and safer approach. The female
urethra is short, being 40mm in length, muscular and
straight. The male urethra is 160mm long, more sensitive
and curved, which can give rise to complications. Passage of a
catheter can be painful and, in the male, the curvature of the
urethra introduces a risk that its tip may cause damage [25].
Some designs of catheters are curved (coude´ and bicoude´) to
minimize this risk. The main problem with suprapubic
catheterization is the risk of perforating the bowel on
insertion of the guidance cannula [26]. Guidelines on
minimizing morbidity associated with suprapubic catheter
usage have been published by the British Association of
Urological Surgeons [27].
Catheter size is usually expressed in French gauge (Fr or
FG¼ circumference in mm). The normal practice is to use the
smallest catheter compatible with good drainage [28]: 12–16
Fr is usually adequate and only rarely is a catheter larger than
18 Fr necessary.
Figure 4. A typical Foley catheter. This
catheter is size 16 Fr. Its overall length is
400mm and the volume of the fully-
inflated balloon is 10ml. The catheter has
two channels. When the catheter has been
inserted, the retaining balloon is inflated with
sterile water from a syringe via the inflation
connector and one of the channels. The
inflation connector incorporates a valve to
prevent the sterile water from escaping when
the syringe is detached. The other channel
allows the free flow of urine from the
drainage eye to the drainage funnel. To
remove the catheter, the retaining balloon is
first deflated by withdrawing the water from
it with a syringe, which opens the valve in the
inflation connector when it is attached.
4 R. C. L. Feneley et al. J Med Eng Technol, Early Online: 1–12
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3. The modern Foley catheter
Foley’s original catheter was made of latex, the mechanical
properties of which are ideal for this purpose: it has a high
stretch ratio, a high level of resilience and it is extremely
waterproof. The main problem with latex is its cytotoxicity:
for instance, in the 1980s, an epidemic of severe urethral
strictures was recorded in patients as the result of using latex
catheters. The cause was traced to cellular toxicity due to
eluates from rubber [29]. Latex catheters are now usually
coated with silicone elastomer to reduce this risk [30].
Many modern catheters are made entirely of silicone elasto-
mer and hydrophilic coatings are used to provide a slippery
surface to reduce friction [31]. Silicone catheters are not only
non-allergenic, but they also have superior resistance to
kinking and better flow properties in comparison with latex
catheters [32].
Emphasis has also been placed on the need for a smooth
surface to the catheter and the drainage eyes [33]. Rough
surfaces encourage the deposition of bacterial biofilm and
sharp edges to the drainage eyes can cause bleeding from
the urethral lining when the catheter is introduced or
withdrawn.
Some catheter research over the last few years has
focused on the development of antiseptic and antimicro-
bial coatings, with the aim of reducing the incidence of
catheter-associated urinary tract infections [34], so far
with negligible success [35] (see also Section 6d). Thus,
a randomized controlled trial performed to compare the
ability and cost-effectiveness of an antiseptic- and
antimicrobial-impregnated catheter vs a standard coated
catheter to minimize the risk of catheter-associated
urinary tract infection revealed no evidence of benefit
[36]. Indeed, in an earlier randomized clinical trial,
infection actually increased with a silver-impregnated
catheter [37].
Some Foley catheters have a third channel, which can be
used to infuse saline or other irrigating fluid into the bladder:
this may be useful when there is a likelihood that blood clots
may form in the bladder, perhaps as the result of post-
operative bleeding. There is also a commercially-available
catheter that has two balloons at the end of the catheter. The
balloon at the tip is intended to reduce the risk of trauma to
the urothelium; the drainage eyes perforate a short section of
catheter between the two balloons, the proximal of which
serves as the retention device. A possible disadvantage of the
dual-balloon catheter is that it may trap more urine in the
bladder at the end of drainage, thus increasing the risk of
bladder infection.
4. Adverse events caused by the Foley catheter
In an editorial in the New England Journal of Medicine in
1988, the American physician, Calvin M. Kunin, published a
comprehensive indictment of the Foley catheter, 51 years after
its introduction into clinical practice [38]. Having acknowl-
edged that the Foley catheter is indispensable in modern
clinical practice to provide temporary relief of urinary
retention, a dry environment for incontinent or comatose
patients and an accurate measurement of urinary output in
those who are seriously ill, his intervention added momentum
to the publication of major contributions covering virtually
every aspect of the subject.
An adverse event is defined as ‘‘any untoward medical
occurrence, unintended disease or injury or any untoward
clinical signs in subjects, users or other persons’’[39]. For an
Figure 5. The Foley catheter, introduced (a)
Urethrally and (b) Suprapubically. In both
cases, the bladder is shown to be draining
continuously into a urine collection bag
attached to the leg: this bag can be emptied
when necessary by opening a valve.
Alternatively, the bladder can be drained
intermittently if a catheter valve is inserted
into the drainage funnel of the catheter.
DOI: 10.3109/03091902.2015.1085600 Urinary catheters 5
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adverse event to be considered to be serious, it should either:
have led to a death; or have led to a serious deterioration in
health that either resulted in life-threatening illness or injury
or permanent impairment of a body structure or body
function, or required in-patient hospitalization or prolonga-
tion of existing hospitalization or resulted in medical or
surgical intervention to prevent life-threatening illness or
injury or permanent impairment of a body structure or a body
function; or led to foetal distress, foetal death or a congenital
abnormality or birth defect [39]. The principal adverse
events—some of which are serious—for which the Foley
catheter is responsible are as follows:
4.1. Bacterial colonization
The flow of urine through an indwelling catheter may be
continuous or intermittent. The introduction of a Foley
catheter without a valve results in continuous drainage and,
thereby, suppresses the normal process by which the build-up
of bacteria is inhibited by periodic flushing. Periodic flushing
is usually facilitated by a manually-operated pinch or rotary
valve. It can also be provided by ‘‘tidal drainage’’, which
allows the bladder to fill and empty automatically [40]. By
raising the height of the drainage tubing leading from the
catheter to a few centimetres above the level of the bladder,
the bladder fills to the corresponding hydrostatic pressure
before a syphon is formed that empties the bladder, after
which the cycle is repeated. In a series of 33 patients with
neurologically-damaged bladders following spinal cord inju-
ries, tidal drainage reduced the rate of infection from 73% to
15% [41]. Although this is a marked improvement and
urethral damage can be avoided by suprapubic catheterization
[42], tidal drainage is seldom used nowadays, possibly
because of the level of nursing care required.
Bacteria can invade the bladder by migrating along the
inside and the outside of the catheter. With short-term
catheterization, the daily infection rate is 5% [16], so that
95% of catheterized patients suffer bacterial invasion after 1
month. Urinary tract infection necessitates the use of
antibiotics, which are all too frequently untested against the
specific bacteria and consequently often prove to be ineffect-
ive until the right one is found by a process of trial and error.
This adds to the cost of clinical management, as well as being
a burden for patients and carers.
4.2. Antibiotic resistance
The use of antibiotics to control catheter-induced infections
contributes significantly to the development of resistant
strains, about which the World Health Organization (WHO)
has expressed grave concern [43]. The WHO referred in
particular to seven bacteria: the first of these, Escherichia
coli, is strongly associated with urinary tract infections.
In five out of the six WHO regions, it was found that the
antimicrobial drugs that were used failed in 50% or more of
the cases investigated. The second bacterium in the list,
Klebsiella pneumonia, which is also found in urinary tract
infections, was similarly resistant. In view of the increasingly
serious threat to global public health identified by the WHO,
the present pervasive lack of interest in research aimed at
finding a better alternative to the Foley catheter is both
disturbing and inexcusable.
4.3. Chronic infection
The balloon of the Foley catheter occupies the base of the
bladder, obstructing the internal urethral orifice, with the
result that 10–100ml of urine remains in the bladder when its
flow has ceased [44]. This sump of residual urine is likely to
be infected, so that uninfected urine descending from the
kidneys will also rapidly become infected, resulting in chronic
infection of the bladder.
Figure 6. A section through a Foley catheter
that has become blocked during use by the
formation of struvite. The smaller patent
lumen is the channel for the inflation and
deflation of the retaining balloon. The length
of the scale bar is 1mm.
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4.4. Kidney and bladder damage
Invasion of the bladder by urease-producing bacteria, par-
ticularly Proteus mirabilis, results in the conversion of urea in
the urine into ammonia [35]. The consequential increase in
the alkalinity of the urine causes phosphates to nucleate out of
solution, forming crystals of struvite (magnesium ammonium
phosphate) and hydroxyapatite (an hydroxylated form of
calcium phosphate in which some of the phosphate groups are
replaced by carbonate). Increasing fluid intake with citrate-
containing drinks increases the pH at which crystals form in
the urine [45] and there is evidence [46,47] that this could be
used to control the rate at which catheter encrustation occurs.
The nucleation of struvite and hydroxyapatite crystals on
the biofilm on the catheter resulting from the activity of the
bacterial urease causes encrustation to form around and
within the catheter, blocking the drainage eyes and the lumen
and preventing the flow of urine (Figure 6). This is a medical
emergency that not only can be excruciatingly painful for the
patient, but that also and more importantly requires a rapid
response (usually the replacement of the blocked catheter) if
permanent damage to the bladder and the kidneys (due to
ureteric reflux) caused by the high bladder pressure is to be
avoided. These problems are exacerbated if associated with
bladder spasm [48]. Moreover, it is apparent that some
patients are more likely to block their catheters than others
[49] (blockers tend to have urine that is more alkaline, which
is consistent with other observations).
It has been reported that, in cases of Proteus mirabilis
infection, the necessity for antibiotics might be avoided by
adding the biocide triclosan to the sterile water used to inflate
the balloon of the Foley catheter. This appears to prevent the
rise in urinary pH that drives biofilm formation and catheter
blockage [50], presumably by leaching into the urine. It is
disappointing, however, that exposure to triclosan has also
been shown to encourage the development of resistant strains
of Proteus mirabilis, so this does not hold out much promise
as a long-term solution [51].
4.5. Bladder stones
The crystals of struvite resulting from Proteus mirabilis
infection act as nuclei for stone formation within the bladder
[52]. Bladder stones entrap Proteus mirabilis bacteria and,
thus, maintain the infection. Recurrent blockage of a catheter
raises a high suspicion that bladder stones may be present.
Endoscopic transurethral techniques are used to remove
bladder stones: fragmentation by crushing (litholapaxy),
shock-wave ultrasound or laser probes may be required to
break them into particles small enough to be washed out of
the bladder through the urethra.
4.6. Pseudopolyps
Insertion into the urethra of a hard unyielding catheter, with
its balloon and its protruding tip perforated by drainage eyes,
transforms the natural process of intermittent drainage.
When the drainage valve at the distal end of the catheter is
opened, the low viscous drag of the catheter allows the urine
to flow rapidly, driven by both the collapsing bladder and
the negative pressure of the hydrostatic column to the open
end of the catheter. Towards the end of the drainage process,
when the bladder wall comes into what is frequently
traumatic contact with the tip of the catheter, the mucosal
lining can be sucked into the drainage eye [53]. Patients may
experience a sharp pain at this stage, sometimes accom-
panied by ‘‘stuttering’’ when the urine flow momentarily
ceases as the result of the bladder wall being sucked into the
drainage eye and then released. This suction can result in the
formation of haemorrhagic pseudopolyps, with cumulative
damage [54].
4.7. Septicaemia
The physical trauma caused by the catheter tip and the suction
at the drainage eyes can damage the normally impermeable
bacterial barrier provided by the urothelial lining of the
bladder (see Section 4.6). This provides direct access for
bacteria into the bladder wall and the bloodstream (bacter-
aemia), with a high risk of septicaemia. Moreover, reflux of
infected urine via the ureters can lead to renal infection
(pyelonephritis) and septicaemia. If inadequately treated,
septicaemia can prove to be fatal [55].
4.8. Urethral trauma
The process of inserting the catheter requires skill and
practice, if urethral trauma is to be avoided [56]. One of the
problems with indwelling catheters with silicone balloons is
that, when the water is removed from the balloon with a
syringe prior to catheter withdrawal, a phenomenon known as
creep may cause the balloon to fail to collapse completely.
This may result in a small rim that can make it difficult or
impossible to to remove the catheter [57]. (This presents a
particular problem in the case of suprapubic catheters because
these pass through a rigid fibrous track into the bladder, rather
than through the urethra with its more elastic muscular walls.)
Even more serious damage can occur if the catheter is
deliberately pulled out when the balloon is still inflated, as
can be done by disorientated or demented patients. In women
with neurological conditions such as multiple sclerosis, the
catheter can be expelled spontaneously by a sudden inappro-
priate contraction of the bladder. Under these circumstances,
the urethra is dilated by the balloon and, if frequently
repeated, the sphincter mechanism may become incompetent.
4.9. Balloon fragments
There is the risk that the catheter balloon may burst, either
during insertion or withdrawal (particularly by a demented or
disorientated patient) or when it is indwelling [58]. If this
should happen, the fragments must be removed, usually with
the aid of a cystoscope, as otherwise they can lead to stone
formation or catheter blockage.
4.10. Commentary
Several of these adverse events are demonstrated in a video
presentation that can be accessed via the internet [59].
It is axiomatic that the incidence of catheter-associated
urinary tract infections can be reduced by reducing unneces-
sary catheter use. There have been numerous studies aimed at
achieving this worthy objective. In reviews of these studies
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[60,61], two effective strategies have been identified. First,
unnecessary placement of indwelling catheters should be
avoided by imposing protocols including, for instance, a
requirement to confirm by ultrasonic scanning that urine is
being retained in the bladder [62]. There are semi-automated
scanners designed for this purpose, but they are not without
their shortcomings [63]. Second, there should be a system to
remind the medical and nursing staff to be aware of the
catheter’s existence, perhaps by means of a daily checklist, to
prompt its removal when no longer necessary. This simple
expedient can have a significant impact.
The achievable goal of the implementation of these two
strategies is typically to reduce the rates of catheter-associated
infections by 25% [60]. These strategies are already being
implemented in many hospitals but, even if they were
universally followed, the Foley catheter would still have to
remain in widespread use.
5. The scale of the burden of urinary incontinence
5.1. Overview
Data from 2006–2007 reveal that 1.3 million people in
England sought help for incontinence problems. The number
had risen to 2.3 million in 2010–2011. Urinary incontinence
increases with age from 14% in individuals aged 65–69 years
to 45% in those aged 85 years or over [64]. The care of older
and disabled people in an ageing population presents a major
challenge: the management of bladder (and bowel) function is
fundamental to the standard of care that they receive. It is
difficult or impossible for those affected to maintain a
reasonable quality-of-life and urinary incontinence is a major
reason for sufferers to seek residential care [65].
In a study of 430 new admissions to nursing homes in the
US, 39% of patients aged 65 years or over suffered from
daytime urinary incontinence [66]. In this setting, catheter-
ization is only recommended as a last resort, because of its
high incidence of urinary tract infections. Elderly patients are
managed by using incontinence pads, but immobile patients
lying on wet pads develop pressure sores. Choosing the lesser
of two evils, the development of a pressure sore is accepted as
an indication for catheterization.
In England, Wales and Northern Ireland (and there is no
reason to suppose that the situation is significantly different in
Scotland), indwelling Foley catheters are used by 3% of
people living in the community and 13% of care home
residents [67].
5.2. Incidence of adverse events
It is a profoundly disturbing statistic that healthcare-
associated urinary tract infections are estimated to have
caused 13 088 deaths in hospitals in the US in 2002 [68].
Assuming that 80% of these were due to catheter-induced
infections [16], that equates to 10 470 deaths. The population
of the US is 4.98-times that of the UK, so the corresponding
annual number of deaths in the UK is probably at least 2100.
In a postal survey to determine the incidence and
morbidity of long-term catheterization in a typical National
Health Service setting [69], there were 506 referrals from a
cohort of 457 patients over a 6-months period. From these
referrals, 54 patients were selected for detailed study: 48%
experienced catheter blockage, 37% reported urine by-passing
the catheter and 30% noted haematuria.
Catheter-associated urinary tract infections not only place
heavy demands on healthcare resources, but their treatment
also raises profound concern regarding the development of
antimicrobial resistance and they cause immense distress and
social problems for the sufferers, their carers and their
communities.
5.3. Economic implications
A rigorous analysis of economic costs of urinary retention,
incontinence and catheterization is beyond the scope of this
review. It may be helpful, however, to give some insight into
the orders of magnitude involved, as follows:
In 2008, the world market for urinary continence care
devices of all kinds (mainly catheters and pads) was estimated
to be US$1.8 billion per year, growing at 7% per year; of
this, Foley catheters accounted for US$380 million in 2007
[70]. The costs of the relevant devices are, however, small in
relation to those of the clinical and societal consequences of
incontinence and retention and its management by long-term
catheterization. In the US in 2002, urinary tract infections
were responsible for over 7 million physician visits; they
accounted for more than 100 000 hospital admissions, mostly
for pyelonephritis; and the direct and indirect costs associated
with community-acquired urinary tract infections exceeded an
estimated US$1.6 billion [71]. In 1997, 15% of all
community-prescribed antibiotics in Germany were dispensed
for urinary tract infections, at an estimated cost of over US$1
billion [72]. In 1991, it was estimated that an episode of
nosocomial bacteriuria added US$500–1000 to the direct cost
of acute-care hospitalization [73].
The use of incontinence pads could be greatly reduced if
there were a satisfactory alternative to the Foley catheter.
In addition to the fact that the use of pads is difficult or
impossible to conceal, thus tending to make sufferers socially
reclusive, there is the further problem of progressive deteri-
oration of the condition of their skin. Unless pads are changed
so frequently that the skin is kept dry, it tends to become
macerated, leading to pressure sores and, with repeated
drenching, the problem becomes chronic and unmanageable.
The cost of pads to the NHS in England increased from £77
million in 2006/2007 to £121 million in 2010/2011, so that
their use has begun to be restricted. Until 2013, the allocation
was based on clinical need. Now it is often based on financial
considerations and, as a result, the allowance per patient can
be as few as four disposable continence products in 24 h [64].
This rationing perversely ignores the downstream costs of
treating the resulting increase in the incidence of pressure
ulcers, many of which are due to the use of pads and which,
in the UK, was already between £1.4–£2.1 billion annually in
2004, accounting for 4% of total NHS expenditure [74].
Clearly it is impossible to make a simple and accurate
calculation of the financial cost attributable to catheter-
associated urinary tract infections. According to hospital
episode statistics, there were 281 296 finished consultant
episodes of serious adverse events related to urinary tract
infections in National Health Service hospitals (and private
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hospitals undertaking work for the NHS) in England and
Wales in 2012–2013 [75]. It is reasonable to assume that 80%
of these episodes (225,036) were due to catheter-induced
infections [16]. Data for 2001 show that infected patients, on
average, incurred UK hospital costs 2.9-times higher than
uninfected patients, at that time equal to an additional £3154
per patient [76]. Between 2001–2014, the UK consumer price
index increased by a factor of 1.48 [77]. Admittedly this may
not be a very good index of healthcare cost inflation, but no
better measure seems to be available. Thus, the additional UK
National Health Service cost of each catheter-associated
urinary tract infection must be in the order of £4600 so, by
this calculation, the total annual cost of all episodes must be at
least £1.0 billion.
Data for Scotland in 1999 [78] gave an estimated £125
million as the additional annual cost of treating catheter-
associated urinary tract infections. Scotland accounts for 8%
of the UK population and financial inflation from 1999 to
2015 was 55%. This calculation indicates that the total
current UK cost of catheter-associated urinary tract infections
is £2.5 billion per year.
Thus, it can be concluded that the annual total additional
UK cost of catheter-associated urinary tract infections prob-
ably now lies somewhere between £1.0–£2.5 billion.
For the US, it was recently estimated that healthcare-
acquired infections account for nearly US$45 billion per year
in direct hospital costs [79]. Assuming that 80% were due to
catheter-induced infections [16], the total annual cost must be
US$36 billion.
Prior to 1 October 2008, hospitals in the US were able to
recover additional payment to compensate for the extra cost of
treatment of catheter-associated urinary tract infections. Then
the Medicare rule was changed and reimbursement for this
was stopped [80]. Whether or not this was justified, the
rationale was that catheter-associated urinary tract infection
could reasonably be prevented through the application of
evidence-based guidelines. Whatever the other effects of this
change in the rule have been, however, it is perhaps surprising
that it does not seem yet to have been seen as an incentive to
develop a better catheter.
Of course, the availability of a better catheter would not
completely eliminate catheter-associated urinary tract infec-
tions but, even if only 50% of its potential could be achieved,
the annual savings would be in the order of £500 million in
the UK and US$18 billion in the US. Furthermore, over 1000
deaths would probably be avoided each year in the UK and
over 5000 in the US.
6. Research agenda
It has rightly been said to be healthcare’s hidden scandal of
neglect that the Foley catheter, a device originated in the
1930s and which is directly responsible for tremendous
morbidity and significant mortality is still in routine long-
term clinical use today [81].
In order to meet this challenge, an alternative indwelling
catheter system must be developed. Taking into account
the data presented in this review, as well as other analyses
[82–84], the following research agenda can be proposed:
(a) The catheter should be easy to insert and withdraw. This
means that the catheter should be flexible and experience
minimal friction with the urethra, possibly by the
application of durable, lubricious, antibacterial and
hydrophilic coating [85].
(b) The catheter should be retained within the bladder. The
mechanism of retention is arguably the pivotal aspect of
design development. The balloon of the Foley catheter
provides a retention force between 9–41 N, depending on
the balloon inflation volume [86], which normally
provides satisfactory retention, but it is associated with
many problems (mainly incomplete urinary drainage,
bladder and urethral damage), so a novel approach is
essential.
(c) The catheter should allow the bladder to fill at low
pressure and to empty completely, mimicking the natural
physiology and without damage to the urothelial lining of
the bladder or the urethra. This ‘‘bioinspired’’ approach,
based on the evidence of normal biological function,
would surely minimize the occurrence of infection. For
instance, an alternative to the balloon of the Foley
catheter as a retention device should minimize the
retained volume of urine. A catheter with numerous
drainage eyes, extending from a suprapubic port to the
urethral opening, could be retained suprapubically, with
negligible volume within the bladder. A collapsible
section in the catheter close to the end of the urethra or
the suprapubic port could serve to restrict the rate of flow
towards the end of drainage and, thus, to reduce the
suction which otherwise could lead to pseudopolyps and
other complications at the drainage eyes of the catheter.
The catheter system should be able to minimize any
increase in bladder pressure (such as that due to muscle
spasm), to avoid damage to the kidneys. One possibility
might be to provide an external reservoir to compensate
for the reduction in the functional capacity of the bladder
when it contracts during a spasm, with the urine flowing
back into the bladder as it subsequently relaxes. Such a
reservoir could also compensate for the reduction in the
structural capacity of the bladder due to long-standing
inflammation.
(d) Catheter blockage is primarily the result of urinary
infection and so the catheter should be resistant to
encrustation by crystalline bacterial biofilm. Attempts to
prevent catheter encrustation by impregnating the cath-
eter surface with antimicrobial agents such as silver (see
Section 3) have failed because of a lack of understanding
of the encrustation process. Thus, it has been shown that,
in patients infected with Proteus mirabilis, crystals
generated in the alkaline urine rapidly cover the silver
surface, protected from the underlying antibacterial agent
[87,88]. The lesson here is clear: if antimicrobials are to
be incorporated into catheters to prevent encrustation,
they must diffuse from the catheter into the urine and,
thus, prevent the bacteria from elevating the urinary pH.
As a precautionary measure, a sensor might be used to
predict imminent encrustation. Such a sensor already
exists: strips of cellulose-acetate/bromothymol-blue poly-
mer change their colour from yellow to dark blue when
the pH of the urine increases due to the presence of
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Proteus mirabilis and this colour change has been shown
reliably to occur some 12 days before catheter blockage
[89]. Moreover, the incidence and severity of catheter
encrustation and blockage could be expected to be
reduced if the normal periodic drainage of the bladder
were to be restored.
(e) There should be an effective method for the safe insertion
of the catheter by the suprapubic route. Ultrasonic
guidance is satisfactory, but only when used by a trained
practitioner [90], so this needs to be deskilled. An
alternative is to construct a permanent continent
suprapubic port by the Mitrofanoff [91] procedure,
which involves the transplantation of the vermiform
appendix and major surgery. In this context, there has
been an attempt to use a plastic gastrostomy button as an
alternative port [92]. Neither of these approaches is
completely satisfactory; research into biomaterials with
tissue-integrating surfaces or scaffolds must be worth
exploring, aimed at developing a prosthetic suprapubic
port suitable for intermittent or indwelling
catheterization.
(f) The catheter should have control mechanisms appropriate
for all users, including those with loss of manual or
cognitive abilities. A valve is needed to mimic the normal
cyclical filling and emptying of the bladder. For users
with manual dexterity and cognitive ability, this valve can
be a simple tap, although a pinch valve is preferable
because it eliminates the possibility of bacterial ingress.
For people who cannot use a manual valve, an electric-
ally-actuated valve is necessary, with pre-set timing for
those for whom that is required: a prototype device
already exists [93].
(g) The intellectual property in the design of the catheter
should be protected, as this will be the catalyst for its
commercial manufacture, without which it cannot be
introduced into clinical practice. The performance of the
catheter will need to be tested in clinical trials and it will
need to be shown to comply with the relevant medical
device regulations. Rigorous cost-benefit analysis will
also be needed to generate the data to justify the
inevitably higher cost than that of the Foley catheter.
Figure 7 illustrates how some of these concepts, several of
which are the subjects of patent applications [94–96], could
be incorporated in a catheter system designed to meet the
specifications of the research agenda.
7. Conclusions
Whilst it is true that the huge clinical, social and economic
costs of the use of the Foley catheter for long-term urinary
drainage have come into sharper focus since the publication of
Kunin’s seminal paper in 1988 [38], it is regrettably also true
that the scientific community, the relevant commercial
companies and the regulatory authorities have largely failed
to seek a solution. Perhaps the scientific community has not
realized that there are significant interdisciplinary research
challenges to be solved. The commercial companies probably
see no reason to upset their business models with disruptive
new technologies. The regulatory authorities apparently
complacently neglect their responsibility to encourage innov-
ation where existing devices are clearly inadequate.
This review ends with a research agenda for the achieve-
ment of safe long-term catheterization. The way forward is
clear: now is the time for the research funders, the healthcare
providers and the regulators to stimulate the scientific,
engineering, commercial and clinical communities to meet
the challenge.
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Figure 7. A catheter incorporating some of the concepts in the research
agenda. The catheter is retained by wings which spring open after
insertion through the suprapubic tract to the bladder: this traps less urine
than the balloon of a Foley catheter and the catheter can be withdrawn
transurethrally after cutting through it at the external suprapubic port.
Multiple drainage eyes in the section of the catheter within the bladder
minimize the risk of the formation of pseudopolyps, and this risk is
further reduced by a collapsible section (shown stippled) of the catheter
situated close to the external meatus of the urethra. The elastic reservoir
at the suprapubic end of the catheter and strapped to the abdominal wall
expands to accommodate urine from the bladder during spasmodic
bladder contraction and returns it to the bladder when it relaxes after the
spasm, thus minimizing the possibility of kidney damage. Periodic
drainage of the bladder into a leg bag is actuated by a pinch valve beyond
the collapsible section of the catheter, under manual or timed automatic
control.
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